Literature DB >> 27143238

Synthesis and biological evaluation of fluoropyrazolesulfonylurea and thiourea derivatives as possible antidiabetic agents.

Hassan M Faidallah1, Manal M Al-Mohammadi1, Khalid A Alamry1, Khalid A Khan1.   

Abstract

Fluorinated pyrazoles, benzenesulfonylurea and thiourea and their cyclic sulfonylthiourea derivatives were prepared as hypoglycemic agents. The chemistry involves the condensation of 4-hydrazino benzenesulfonamide hydrochloride with fluorochalcones to give pyrazoline derivatives which upon oxidation with bromine water afforded corresponding pyrazoles. Reaction of pyrazolines with isocyanates and isothiocyanates give the corresponding ureas and thioureas. Subsequent cyclization of these thiourea derivatives with ethyl bromoacetate and α-bromoacetophenone yielded the 4-oxothiazolidines and thiazolines, respectively. Preliminary biological screening of the prepared compounds revealed significant antidiabetic activity. Molecular and biological properties calculations revealed favorable drug-like profiles of six compounds. The structure-activity relationship (SAR) and in silico drug relevant properties calculations (HBD, HBA, tPSA, miLogP, molecular weight, % ABS, drug-likeness and drug score) endorse that these compounds are potential leads for future drug discovery study.

Entities:  

Keywords:  Antidiabetic activity; benzenesulfonylureas; fluorinated pyrazoles; molecular properties calculations; thioureas

Mesh:

Substances:

Year:  2016        PMID: 27143238     DOI: 10.1080/14756366.2016.1180594

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  7 in total

1.  Novel series of 1,2,4-trioxane derivatives as antimalarial agents.

Authors:  Mithun Rudrapal; Dipak Chetia; Vineeta Singh
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

2.  Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors.

Authors:  Andrea Angeli; Victor Kartsev; Anthi Petrou; Mariana Pinteala; Volodymyr Brovarets; Roman Vydzhak; Svitlana Panchishin; Athina Geronikaki; Claudiu T Supuran
Journal:  Molecules       Date:  2021-11-20       Impact factor: 4.411

3.  Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists.

Authors:  Mohamed A Abdelgawad; Khaled El-Adl; Sanadelaslam S A El-Hddad; Mostafa M Elhady; Nashwa M Saleh; Mohamed M Khalifa; Fathalla Khedr; Mohamed Alswah; AbdElAziz A Nayl; Mohammed M Ghoneim; Nour E A Abd El-Sattar
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-14

4.  New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations.

Authors:  Adnan A Bekhit; Eskedar T Lodebo; Ariaya Hymete; Hanan M Ragab; Salma A Bekhit; Kikuko Amagase; Afnan Batubara; Mohammed A S Abourehab; Alaa El-Din A Bekhit; Tamer M Ibrahim
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

5.  Mononuclear Tricoordinate Copper(I) and Silver(I) Halide Complexes of a Sterically Bulky Thiourea Ligand and a Computational Insight of Their Interaction with Human Insulin.

Authors:  Awal Noor; Sadaf Qayyum; Farukh Jabeen; Ashfaq Ur Rehman
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

6.  Assessment of Antidiabetic Activity of the Shikonin by Allosteric Inhibition of Protein-Tyrosine Phosphatase 1B (PTP1B) Using State of Art: An In Silico and In Vitro Tactics.

Authors:  Mohd Saeed; Ambreen Shoaib; Munazzah Tasleem; Nadiyah M Alabdallah; Md Jahoor Alam; Zeina El Asmar; Qazi Mohammad Sajid Jamal; Fevzi Bardakci; Saad S Alqahtani; Irfan Ahmad Ansari; Riadh Badraoui
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

7.  Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies.

Authors:  Andrea Angeli; Victor Kartsev; Anthi Petrou; Boris Lichitsky; Andrey Komogortsev; Mariana Pinteala; Athina Geronikaki; Claudiu T Supuran
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.